Qsam Biosciences Inc (QSAM) Key Ratios
$8.30
As on 02-May-2024 15:59EDT
Market cap
$37 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
201.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 58.62 | 60.45 | 27.81 | -224.84 | -601.77 |
| Net Profit | 58.44 | 72.65 | 19.13 | -6.26 | -255.39 |
| EPS | 60.25 | 84.68 | 48.75 | 25.28 | 13.03 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-23 | Dec-22 | Dec-21 |
| EBIT-Margin
| -- | -147.70 | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 1,183.58 | 749.54 | 1,617.91 | 1,294.60 | 638.21 |
| Return on Capital
| -2,797.74 | -1,213.86 | 10,415.06 | -13,868.48 | -4,939.80 |
| Return on Assets
| -843.81 | -8,348.52 | -424.48 | -597.19 | -1,509.77 |
| Debt to Equity (x)
| -- | -- | 0.01 | -0.37 | 2.08 |
Profitability
ROCE
10,415.06
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
10,415.06
|
-13,868.48
|
-4,939.80
|
1,460.21
|
863.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
1,617.91
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
1,617.91
|
1,294.60
|
638.21
|
132.14
|
64.83
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-424.48
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
-424.48
|
-597.19
|
-1,509.77
|
-36,486.28
|
-2,724.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
--
|
--
|
--
|
-168.65
|
-126.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
--
|
--
|
--
|
-681.65
|
-250.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
--
|
--
|
-1.00
|
-0.14
|
26.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
27.74
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
27.74
|
50.54
|
-733.68
|
-13.98
|
-93,606.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
27.68
--
Year on year growth in profit after tax
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
27.68
|
52.41
|
-138.47
|
-133.13
|
-478.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.59
--
Year on year growth in earnings per share
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
0.59
|
0.81
|
-58.18
|
0.75
|
0.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.01
--
Total debt / Net worth
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
0.01
|
-0.37
|
2.08
|
-0.92
|
-0.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
0.01
|
-0.37
|
2.08
|
-0.90
|
-0.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.65
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
1.65
|
0.23
|
1.20
|
0.01
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-74.90
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
-74.90
|
-73.41
|
-14.00
|
-2.70
|
-2.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
--
|
--
|
--
|
53.53
|
10.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
--
|
--
|
--
|
0.00
|
210,004.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-5.01
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
-5.01
|
-1.41
|
-0.01
|
-1.86
|
-0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
32.75
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
32.75
|
-7.07
|
0.51
|
-2.33
|
-0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-5.23
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
Qsam Biosciences Inc (QSAM)
|
-5.23
|
-1.62
|
0.07
|
-3.09
|
-33.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|